308 related articles for article (PubMed ID: 24664847)
1. Cardiac iron overload in sickle-cell disease.
Meloni A; Puliyel M; Pepe A; Berdoukas V; Coates TD; Wood JC
Am J Hematol; 2014 Jul; 89(7):678-83. PubMed ID: 24664847
[TBL] [Abstract][Full Text] [Related]
2. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
[TBL] [Abstract][Full Text] [Related]
3. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
[TBL] [Abstract][Full Text] [Related]
4. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
Badawy SM; Liem RI; Rigsby CK; Labotka RJ; DeFreitas RA; Thompson AA
Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
[TBL] [Abstract][Full Text] [Related]
6. No evidence for myocardial iron overload and free iron species in multitransfused patients with sickle/beta-thalassaemia.
Ghoti H; Goitein O; Koren A; Levin C; Kushnir T; Rachmilewitz E; Konen E
Eur J Haematol; 2010 Jan; 84(1):59-63. PubMed ID: 19793250
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic iron loading in chronically transfused sickle cell disease is lower than in thalassaemia major.
Noetzli LJ; Coates TD; Wood JC
Br J Haematol; 2011 Jan; 152(2):229-33. PubMed ID: 21118197
[TBL] [Abstract][Full Text] [Related]
9. Pituitary iron and volume predict hypogonadism in transfusional iron overload.
Noetzli LJ; Panigrahy A; Mittelman SD; Hyderi A; Dongelyan A; Coates TD; Wood JC
Am J Hematol; 2012 Feb; 87(2):167-71. PubMed ID: 22213195
[TBL] [Abstract][Full Text] [Related]
10. Chronically transfused pediatric sickle cell patients are protected from cardiac iron overload.
Kaushik N; Eckrich MJ; Parra D; Yang E
Pediatr Hematol Oncol; 2012 Apr; 29(3):254-60. PubMed ID: 22303979
[TBL] [Abstract][Full Text] [Related]
11. Tissue iron evaluation in chronically transfused children shows significant levels of iron loading at a very young age.
Berdoukas V; Nord A; Carson S; Puliyel M; Hofstra T; Wood J; Coates TD
Am J Hematol; 2013 Nov; 88(11):E283-5. PubMed ID: 23861216
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
[TBL] [Abstract][Full Text] [Related]
13. Assessment of cardiac iron deposition in sickle cell disease using 3.0 Tesla cardiovascular magnetic resonance.
Ibrahim el-SH; Rana FN; Johnson KR; White RD
Hemoglobin; 2012; 36(4):343-61. PubMed ID: 22563880
[TBL] [Abstract][Full Text] [Related]
14. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies.
Jastaniah W; Harmatz P; Pakbaz Z; Fischer R; Vichinsky E; Walters MC
Pediatr Blood Cancer; 2008 Feb; 50(2):319-24. PubMed ID: 17557314
[TBL] [Abstract][Full Text] [Related]
15. Nontransferrin-bound iron in transfused patients with sickle cell disease.
Inati A; Musallam KM; Cappellini MD; Duca L; Taher AT
Int J Lab Hematol; 2011 Apr; 33(2):133-7. PubMed ID: 21382180
[TBL] [Abstract][Full Text] [Related]
16. Myocardial Iron Overload in Sickle Cell Disease: A Rare But Potentially Fatal Complication of Transfusion.
Tavares AHJ; Benites BD; Fertrin KY
Transfus Med Rev; 2019 Jul; 33(3):170-175. PubMed ID: 31153715
[TBL] [Abstract][Full Text] [Related]
17. Myocardial iron overload in thalassaemia major. How early to check?
Borgna-Pignatti C; Meloni A; Guerrini G; Gulino L; Filosa A; Ruffo GB; Casini T; Chiodi E; Lombardi M; Pepe A
Br J Haematol; 2014 Feb; 164(4):579-85. PubMed ID: 24460526
[TBL] [Abstract][Full Text] [Related]
18. Patterns of liver iron accumulation in patients with sickle cell disease and thalassemia with iron overload.
Hankins JS; Smeltzer MP; McCarville MB; Aygun B; Hillenbrand CM; Ware RE; Onciu M
Eur J Haematol; 2010 Jul; 85(1):51-7. PubMed ID: 20374273
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic iron and glucose dysregulation in thalassemia major.
Noetzli LJ; Mittelman SD; Watanabe RM; Coates TD; Wood JC
Am J Hematol; 2012 Feb; 87(2):155-60. PubMed ID: 22120775
[TBL] [Abstract][Full Text] [Related]
20. Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention.
Kwiatkowski JL; Cohen AR; Garro J; Alvarez O; Nagasubramanian R; Sarnaik S; Thompson A; Woods GM; Schultz W; Mortier N; Lane P; Mueller B; Yovetich N; Ware RE;
Am J Hematol; 2012 Feb; 87(2):221-3. PubMed ID: 22120913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
